We next explored the expression of LILRB4 on tumor-infiltrating immune cells from a variety of murine and human tumors by flow cytometry; it was highly expressed on CD45+ cells in most murine tumor models and cancer patients (Fig. 1, E and F). This evidence concerns the gene PTPRC and neoplasm.